social media’s impact in driving a proactive and engaged ... miller presentation_4 8 10.pdf ·...
TRANSCRIPT
Social Media’s Impact In Driving
A Proactive and Engaged Patient
4/8/10
All information contained herein is confidential and/or proprietary information of Epsilon Data Management, LLC.
Any unauthorized use and/or any disclosure is strictly prohibited. Page 2
Setting The Stage: FDA’s Internet & Social Media
Public Hearing
To what extent should manufacturers be
accountable for product information online?P
How fair balance information should be
presented in light of space limitations P
What are the parameters for correcting
inaccurate product information?P
Use of linksP
Reporting of adverse eventsP
What should the rules be for online marketing, including social media?
All information contained herein is confidential and/or proprietary information of Epsilon Data Management, LLC.
Any unauthorized use and/or any disclosure is strictly prohibited. Page 3
Objectives of Presentation
1. Assess how engagement in Social Media (SM) drives a
more knowledgeable, skilled and confident patient
2. The role of pharma in SM participation
All information contained herein is confidential and/or proprietary information of Epsilon Data Management, LLC.
Any unauthorized use and/or any disclosure is strictly prohibited. Page 4
Methodical Approach
From where do individuals get their information?
Why and how do individuals engage
in social media?
Who engages in social media?
How does social media participation
drive a more “activated” patient?
What should pharma’s role be?
70+ agency
presentations
Manhattan
Research/Forrester/
Pew Internet Research
Dose or Digital
• OTC Weight loss drug
• Online Community: MyAlli
Alli
• Multiple Sclerosis
• Online Community: MS-Gateway
Betaseron
• Hypotrichosis
Latisse
E-Rewards
1,350 completes
Multiple dimension
Literature Review/Gap Assessment
SM Campaign Listening
Survey
All information contained herein is confidential and/or proprietary information of Epsilon Data Management, LLC.
Any unauthorized use and/or any disclosure is strictly prohibited. Page 5
Illegitimate noise hinders the conversation
At least a fifth of observed posts are noise
All information contained herein is confidential and/or proprietary information of Epsilon Data Management, LLC.
Any unauthorized use and/or any disclosure is strictly prohibited. Page 6
Product/health websites are almost as important as
HCPs when it comes to health information
88%
Interaction
with HCPs
75%
Health
Website
26%
Other
Sources
Newspaper/Magazine Articles
TV Ads
Email Messages
Direct Mail Postcard/Brochure
Coupons
Messages on Mobile Devices
51%
POC
Sources
All information contained herein is confidential and/or proprietary information of Epsilon Data Management, LLC.
Any unauthorized use and/or any disclosure is strictly prohibited. Page 7
The larger web properties attract more visits…
but they lend credibility to varying degrees
Credibility
Visits
High
Low
Low High
All information contained herein is confidential and/or proprietary information of Epsilon Data Management, LLC.
Any unauthorized use and/or any disclosure is strictly prohibited. Page 8
Consumers are focused. They’re searching for
“foundational” information
49%Information about a
specific condition/disease
28%Symptom checker
23%Information about
drugs & supplements
23%Latest health
news20%
General health
topics
Other:
19% - Health encyclopedia
14% - Find a drug
14% - Questions to ask your
doctor
13% - Glossary of terms
12% - Alternative recipe
12% - Recipes
8% - Support and advice on
how to manage my life
7% - Free newsletters
5% - Message board
5% - Doctor search
4% - Blogs
3% - Support groups
All information contained herein is confidential and/or proprietary information of Epsilon Data Management, LLC.
Any unauthorized use and/or any disclosure is strictly prohibited. Page 9
Evaluation of the three SM campaigns confirms this
3728
8151
1201
1565
195
317
245
0
1000
2000
3000
4000
5000
6000
7000
8000
9000
Alli Betaseron Latisse
Observed Conversation Volume
Disease State + Brand + Campaign
Disease State + Brand
Disease State
36%
54%
9%
All information contained herein is confidential and/or proprietary information of Epsilon Data Management, LLC.
Any unauthorized use and/or any disclosure is strictly prohibited. Page 10
40% of online users engage in social media,
but what counts as an engagement?
51%A few times
a year
Participation on health
related websites
5%Every day
or almost
every day
19%On a weekly
basis
25%Once a
month
49%Forums/
Message Boards
11%Support
Groups
20%Blogs
20%Wikis
SM tools leveraged
All information contained herein is confidential and/or proprietary information of Epsilon Data Management, LLC.
Any unauthorized use and/or any disclosure is strictly prohibited. Page 12
Participation in SM provides reassurance and intimacy
55%I find comfort in
knowing I’m not the
only one who is going
through what I’m
going through
53%It helps me
find answers to my
health from people
like me/with my
condition
Talking to others
gives me
peace of mind
It empowers me
to do more
It helps me to solve
my health problems
It helps me reach
my health goals
All information contained herein is confidential and/or proprietary information of Epsilon Data Management, LLC.
Any unauthorized use and/or any disclosure is strictly prohibited. Page 13
Lack of participation in SM is both a time and trust
issue
79%I rely on my
doctor’s advice
48%I just don’t
have the time
43%I don’t really
trust what others
are saying
I find that there is too
much information
I find it hard to use
the information
I find it difficult to
use what I read
I’m not comfortable
with the technology
and how to navigate
All information contained herein is confidential and/or proprietary information of Epsilon Data Management, LLC.
Any unauthorized use and/or any disclosure is strictly prohibited. Page 14
Clear factors drive engagement in SM
I research the latest
developments in
therapy
Younger
Caregiver of person
with multiple
conditions
Getting support and
encouragement from
people who have similar
health problems as mine
is helpful to me
Lower health
activation levels
I really care how
others are dealing
with their condition
All information contained herein is confidential and/or proprietary information of Epsilon Data Management, LLC.
Any unauthorized use and/or any disclosure is strictly prohibited. Page 15
A PAM score reveals an individual’s position along a continuum of increasing health activation
Scientifically validated measure (10 or 13 questions) that assesses three core domains – knowledge, skills and confidence, that drive health behavior
Sample Questions:#1: “When all is said and done, I am the person who is responsible for taking care of my health.”
#12: “I am confident I can figure out solutions when new problems arise with my health”
All information contained herein is confidential and/or proprietary information of Epsilon Data Management, LLC.
Any unauthorized use and/or any disclosure is strictly prohibited. Page 16
SM users are distinguished by two broad
activation/behavioral types
0%
10%
20%
30%
40%
50%
60%
70%
80%
90%
100%
US Population Online/No SM SM Participator
PAM Segment Distribution
PAM 1 PAM 2 PAM 3 PAM 4
All information contained herein is confidential and/or proprietary information of Epsilon Data Management, LLC.
Any unauthorized use and/or any disclosure is strictly prohibited. Page 17
SM users are better equipped to manage their health
SM
User
Non
User
(1)I understand my condition a lot better
(2)I feel as though I can do a lot
more to improve my health
(3) I feel better knowing that there
are others just like me
(4) I know that there is a place
that I can go to for support
(5)I now know how to have an
informed conversation with
my health care professional
(6)I’m more confident in having a
discussion with my doctor
about my health
(7)I’m more confident in having
a discussion with my
doctor about my
therapy/drug choices
Relative Importance
All information contained herein is confidential and/or proprietary information of Epsilon Data Management, LLC.
Any unauthorized use and/or any disclosure is strictly prohibited. Page 18
What Role Should Pharma
Play in Social Media?
A Customer’s POV
All information contained herein is confidential and/or proprietary information of Epsilon Data Management, LLC.
Any unauthorized use and/or any disclosure is strictly prohibited. Page 19
Individuals are guarded about pharma’s involvement in SM…
yet endorsement by non-profit organizations, the FDA and
third party watch dog groups adds credibility
1%
40%
44%
15%
Consumers Feelings About Pharma's Participation in SM
Healthcare companies are looking out for my best interests
Healthcare companies care about my best interests but also have their own interests in mind
Healthcare companies care little about my best interests and mostly looking out for themselves
Healthcare companies are only looking out for themselves
69%58%
50%
13%
HC Non Profit
FDA 3rd Party Watchdog
Pharma Co.
Adds Credibility (Top 2 Box %)
All information contained herein is confidential and/or proprietary information of Epsilon Data Management, LLC.
Any unauthorized use and/or any disclosure is strictly prohibited. Page 20
Individuals are not resistant to pharma monitoring
user’s comments…but to a limited degree
42%The company should be
required to monitor all users’
post for accuracy
25%Pharma companies should
not be allowed to comment
on blogs or forums
52%The company should be
allowed (but not required) to
respond to the users’ post at
its discretion
51%If the company responds to
correct other users’ posts
that put the company in a
negative light, then it should
also be required to correct
posts that are too “friendly”
to the company
45%The company should be
responsible only for correcting
inaccurate statements that
pose a threat to safety
All information contained herein is confidential and/or proprietary information of Epsilon Data Management, LLC.
Any unauthorized use and/or any disclosure is strictly prohibited. Page 21
Side effects are a common topic within brand related
conversations
77%I’ve read about side
effects of the
medication
66%I’ve read about the
benefits of the
medication
46%I talk about the side
effects of medication
43%I have questions
about how well
a particular
medication works
All information contained herein is confidential and/or proprietary information of Epsilon Data Management, LLC.
Any unauthorized use and/or any disclosure is strictly prohibited. Page 22
Side effects were mentioned in 17% of brand-related
results…and this is significantly under-measured
• Dealing with treatment and weighing treatment options
• Living with MS
• Seeking advice or support
Betaseron
• Experience taking Alli
• General diet and weight loss discussions
• Debating the worth or necessity of weight loss drugs like Alli
• Other diet products
Alli
• Effectiveness of Latisse versus other products and cosmetics
• Cost concerns
Latisse
Other Common Topics of Brand Related Conversations
All information contained herein is confidential and/or proprietary information of Epsilon Data Management, LLC.
Any unauthorized use and/or any disclosure is strictly prohibited. Page 23
When consumers read a post about a medication
concern, they want validation
45%I’d like for someone
to validate that the
comment is correct
38%I take the comment
with a grain of salt
All information contained herein is confidential and/or proprietary information of Epsilon Data Management, LLC.
Any unauthorized use and/or any disclosure is strictly prohibited. Page 24
Consumers want pharma companies to validate
discussions about drug side effects
55%I expect them to let
me know if the
information is correct
32%I expect them to
provide me with
a perspective
on the comment
All information contained herein is confidential and/or proprietary information of Epsilon Data Management, LLC.
Any unauthorized use and/or any disclosure is strictly prohibited. Page 25
Opinions about how pharma should best respond are
not that strong
39%Post a personalized
response with advice
38%Post a response with
links to information
37%Contact me privately
for more information
All information contained herein is confidential and/or proprietary information of Epsilon Data Management, LLC.
Any unauthorized use and/or any disclosure is strictly prohibited. Page 26
Essential findings summarized
Individuals who engage in SM fall into two broad groups; highly
engaged patients who take an active role in health management
(80%) versus those who lack confidence to play an active role in
their own health (20%). Efforts must be tailored to these distinct
patient groups
Satisfy the core informational needs…but don’t forget about the
emotional needs
The SM platform must focus on driving a stronger call to action
Consumers want pharma to participate in SM. They do not want
to be marketed too but want pharma to validate that the
information they are getting is accurate
Endorsement from a credible 3rd party source adds integrity…and
it does not need to be the FDA. Integrity is key to driving a level
of trust that welcomes participation
All information contained herein is confidential and/or proprietary information of Epsilon Data Management, LLC.
Any unauthorized use and/or any disclosure is strictly prohibited. Page 27
Questions
Mark Miller
Senior Vice President,
Strategic and Analytic Consulting
Epsilon
617-571-7181